Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




GA Assay Better for Monitoring Diabetic Kidney Patients

By LabMedica International staff writers
Posted on 09 Jun 2011
The glycated albumin (GA) assay appears to be far more effective than the hemoglobin A1c (HbA1c) for managing patients with diabetes and advanced kidney failure.

A study evaluated 444 patients with diabetes undergoing dialysis. More...
Patients continued their normal treatment and HbA1c monitoring, but also agreed to have a GA test every three months for an average of more than 2.3 years.

Barry I. Freedman, MD, John H. Felts III Professor at the Wake Forest Baptist Medical Center (Winston-Salem, NC, USA) and colleagues compared the patients' HbA1c and GA test results, assessing their ability to predict hospitalizations and survival. They found that the HbA1c failed to predict medical outcomes. In contrast, the GA was a strong predictor of patient survival and hospitalizations.

The GA test, developed by Asahi Kasei Pharma Corp. (Tokyo, Japan), measures blood sugars over the past 17 days, as opposed to the longer time frame for HbA1c. In situations where rapid changes occur in blood sugar, the GA gives a more accurate picture of diabetes control. The GA test used in this study is available in Japan, China, and South Korea, but is not yet approved by the US Food and Drug Administration (FDA; Silver Spring, MD, USA).

The gold standard long-term glucose-monitoring test for patients with diabetes is the HbA1c test. It measures an individual's average blood sugar level over the prior three months. It is the most commonly used long-term blood sugar test, and is widely trusted in the medical community.

However, HbA1c results are only accurate when red cells have a normal lifespan. Dialysis patients have shorter red cell survival-- reducing the time that sugar in the bloodstream has to interact with hemoglobin, and causing lower HbA1c values.

The study appeared online in the May 19, 2011 edition of Clinical Journal of the American Society of Nephrology.

Related Links:

Wake Forest Baptist Medical Center
Asahi Kasei Pharma Corp.
US Food and Drug Administration



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Nucleic Acid Purification Instrument
QIAsymphony Connect
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.